Market Cap 11.04B
Revenue (ttm) 1.67B
Net Income (ttm) 356.98M
EPS (ttm) N/A
PE Ratio 30.07
Forward PE 23.84
Profit Margin 21.39%
Debt to Equity Ratio 0.30
Volume 200
Avg Vol 926
Day's Range N/A - N/A
Shares Out 282.27M
Stochastic %K 87%
Beta 0.10
Analysts Strong Sell
Price Target N/A

Company Profile

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides pharmaceutical products, which includes Nubeqa for the treatment of prostate cancer; Entacapone, Stalevo, Comtess, and Comtan to treat Parkinson's disease; Burana for inflammatory pain; Divina series for menopausal symptoms; Simdax for acute decompensated heart failure; Far...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 358 10 4261
Address:
Orionintie 1A, Espo, Finland
Latest News on ORINY
No data available.